Aude De Gassart

3.5k citations

42 papers · 2.6k indexed · 2 hit papers · h-index 20

Co-authors: Michel Vidal Charles Géminard Graça Raposo Benoît Février Lionel Blanc Fabio Martinon Evelina Gatti Olivier Demaria
Topics: Immune Cell Function and Interaction (16 papers)CAR-T cell therapy research (15 papers)Immunotherapy and Immune Responses (13 papers)
Cited by: Immunology Cancer Research Molecular Biology
Journals: Science Proceedings of the National Academy of Sciences Journal of Clinical Investigation
Partner nations: France United States Switzerland

In The Last Decade

Aude De Gassart

39 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lipid raft-associated protein sorting in exosomes

2003 540 citations Aude De Gassart, Charles Géminard et al. Blood profile →
STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity

2015 447 citations Olivier Demaria, Aude De Gassart et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Aude De Gassart

Since Specialization

Citations

This map shows the geographic impact of Aude De Gassart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aude De Gassart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aude De Gassart more than expected).

Fields of papers citing papers by Aude De Gassart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aude De Gassart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aude De Gassart. The network helps show where Aude De Gassart may publish in the future.

Co-authorship network of co-authors of Aude De Gassart

This figure shows the co-authorship network connecting the top 25 collaborators of Aude De Gassart. A scholar is included among the top collaborators of Aude De Gassart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aude De Gassart. Aude De Gassart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	γ9δ2 T-cell (γ9δ2TC) activation with ICT01 and azacitidine-venetoclax (Aza-Ven) induces high rates of remission and overall survival in patients with newly diagnosed (ND) acute myeloid leukemia (AML): Results from the phase 1/2 study eviction 2025 ·Blood ·Sylvain Garciaz,(unknown),Pierre Péterlin,Daniel Morillo,José Miguel Torregrosa Diaz,Matthew L. Ulrickson,(unknown),Aude De Gassart,(unknown),Maelle Mairesse,George Saad,(unknown),Katrien Lemmens,(unknown),D Olive,Stephan Braun,Naval Daver,Abhishek Maiti	0
2	ICT01, an Investigational γ9δ2 T Cell Activator, Added to Azacitidine-Venetoclax Achieves Frequent and Early Complete Remissions in Adults with AML Unfit for Intensive Induction Chemotherapy: Interim Results from the Ongoing Open-Label, Randomized Phase 1 Study Eviction 2024 ·Blood ·Abhishek Maiti,(unknown),Pierre Péterlin,Daniel Morillo,José Miguel Torregrosa Diaz,Paul Koller,Maelle Mairesse,(unknown),(unknown),Aude De Gassart,Katrien Lemmens,Daniel Olive,Naval Daver,Stephan Braun,Sylvain Garciaz	1
3	EVICTION study: ICT01, an anti-Butyrophilin 3A monoclonal antibody activating γ9δ2 T cells in combination with pembrolizumab in checkpoint inhibitor refractory melanoma. 2024 ·Journal of Clinical Oncology ·Stéphane Champiat,Martin Wermke,Cécile Vicier,Johann S. de Bono,Emiliano Calvo,(unknown),Evan Hall,Elena Garralda,(unknown),Emanuela Romano,Antoîne Italiano,Esma Saâda,Benoît You,Aude De Gassart,Maelle Mairesse,Emmanuel Di Valentin,(unknown),Daniel Olive,Katrien Lemmens,Paul Frohna,(unknown)	2
4	Abstract CT179: First-in-human study of ICT01, an anti-BTN3A activating monoclonal antibody in combination with low dose IL-2 in patients with advanced solid tumors (EVICTION-2 study) 2023 ·Cancer Research ·Johann S. de Bono,Stéphane Champiat,François‐Xavier Danlos,Martin Wermke,Volker Kunzmann,Aude De Gassart,(unknown),(unknown),Maelle Mairesse,(unknown),Katrien Lemmens,Aurélien Marabelle,Daniel Olive,Paul Frohna	1
5	715 ICT01 plus low dose SC IL-2 produces a robust anti-tumor immune activation in advanced cancer patients (EVICTION-2 Study) 2023 ·SHILAP Revista de lepidopterología ·Johann S. de Bono,Stéphane Champiat,François‐Xavier Danlos,Martin Wermke,Volker Kunzmann,Aude De Gassart,(unknown),(unknown),(unknown),Maelle Mairesse,(unknown),Katrien Lemmens,Daniel Olive,Paul Frohna	3
6	The aspartyl protease DDI2 drives adaptation to proteasome inhibition in multiple myeloma 2022 ·Cell Death and Disease ·(unknown),(unknown),(unknown),Aude De Gassart,Léa Zaffalon,Fabio Martinon	11
7	The protease DDI2 regulates NRF1 activation in response to cadmium toxicity 2022 ·iScience ·(unknown),Aude De Gassart,Sarah E. Bettigole,Léa Zaffalon,(unknown),(unknown),(unknown),Fabio Martinon	6
8	BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells 2021 ·Cell Reports ·Carla E. Cano,Christine L. Pasero,Aude De Gassart,Clément Kerneur,Mélanie Gabriac,(unknown),(unknown),(unknown),Emmanuel Scotet,(unknown),Thomas Herrmann,Caroline Imbert,Laurent Gorvel,Norbert Vey,Antoine Briantais,Anne Floch,Daniel Olive	57
9	Impairment of both IRE1 expression and XBP1 activation is a hallmark of GCB DLBCL and contributes to tumor growth 2017 ·Blood ·(unknown),Aude De Gassart,(unknown),Olivier Demaria,Léa Zaffalon,Sonia T. Chelbi,Michel Gilliet,Francesco Bertoni,Fabio Martinon	39
10	AIM2 inflammasome is activated by pharmacological disruption of nuclear envelope integrity 2016 ·Proceedings of the National Academy of Sciences ·(unknown),(unknown),Jérôme Lugrin,Yvan Jamilloux,(unknown),Aubry Tardivel,Aude De Gassart,Léa Zaffalon,(unknown),Stefanie Siegert,Manfredo Quadroni,Petr Brož,Thomas Henry,Christine A. Hrycyna,Fabio Martinon	115
11	Pharmacological eEF 2K activation promotes cell death and inhibits cancer progression 2016 ·EMBO Reports ·Aude De Gassart,Olivier Demaria,(unknown),Léa Zaffalon,Alexey G. Ryazanov,Michel Gilliet,Fabio Martinon	29
12	Tuning of Natural Killer Cell Reactivity by NKp46 and Helios Calibrates T Cell Responses 2012 ·Science ·Émilie Narni-Mancinelli,Baptiste N. Jaeger,Claire Bernat,Aurore Fenis,Sam K. P. Kung,Aude De Gassart,Sajid Mahmood,Marta Gut,Simon Heath,Jordi Estellé,Elodie Bertosio,Frédéric Vely,Louis N. Gastinel,Bruce Beutler,Bernard Malissen,Marie Malissen,Éric Vivier,Sophie Ugolini	150
13	TLR8 deficiency leads to autoimmunity in mice 2010 ·Journal of Clinical Investigation ·Olivier Demaria,Philippe P. Pagni,Stephanie Traub,Aude De Gassart,Nora Branzk,Andrew Murphy,David M. Valenzuela,George D. Yancopoulos,Richard A. Flavell,Lena Alexopoulou	154
14	MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation 2008 ·Proceedings of the National Academy of Sciences ·Aude De Gassart,Voahirana Camosseto,Jacques Thibodeau,Maurizio Ceppi,Nadia Catalan,Philippe Pierre,Evelina Gatti	205
15	Interleukin‐10‐induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes 2008 ·European Journal of Immunology ·Jacques Thibodeau,Marie‐Claude Bourgeois‐Daigneault,(unknown),Jessy Tremblay,(unknown),Mathieu Houde,Eric Bartee,Alexandre Brunet,(unknown),Aude De Gassart,Evelina Gatti,Martin Baril,(unknown),Séverine Bontron,Klaus Früh,Daniel Lamarre,Viktor Steimle	138
16	Exosomal sorting of the cytoplasmic domain of bovine leukemia virus TM Env protein 2008 ·Cell Biology International ·Aude De Gassart,Bernadette Trentin,Marianne Martin,Agnès Hocquellet,Pascale Bette‐Bobillo,R. Mamoun,Michel Vidal	19
17	Exosome release by reticulocytes—An integral part of the red blood cell differentiation system 2005 ·Blood Cells Molecules and Diseases ·Lionel Blanc,Aude De Gassart,Charles Géminard,Pascale Bette‐Bobillo,Michel Vidal	87
18	Exosome Secretion: The Art of Reutilizing Nonrecycled Proteins? 2004 ·Traffic ·Aude De Gassart,Charles Géminard,Dick Hoekstra,Michel Vidal	125
19	Degradation of AP2 During Reticulocyte Maturation Enhances Binding of Hsc70 and Alix to a Common Site on TfR for Sorting into Exosomes 2004 ·Traffic ·Charles Géminard,Aude De Gassart,Lionel Blanc,Michel Vidal	164
20	Prion‐like protein Doppel expression is not modified in scrapie‐infected cells and in the brains of patients with Creutzfeldt–Jakob disease 2003 ·FEBS Letters ·Katell Peoc’h,Hervé Volland,Aude De Gassart,P. Beaudry,V. Sazdovitch,Maria Catia Sorgato,Christophe Créminon,Jean Laplanche,Sylvain Lehmann	17

About Aude De Gassart

Aude De Gassart is a scholar working on Immunology, Oncology and Molecular Biology, having authored 42 papers that have together received 2.6k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (16 papers), CAR-T cell therapy research (15 papers) and Immunotherapy and Immune Responses (13 papers). The work is most often cited by research in Immunology (1.4k citations), Cancer Research (405 citations) and Molecular Biology (1.5k citations). Aude De Gassart has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Michel Vidal, Charles Géminard, Graça Raposo, Benoît Février, Lionel Blanc, Fabio Martinon, Evelina Gatti, Olivier Demaria, Philippe Pierre and Michel Gilliet. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact